S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

InnovaDerma (IDP) Share Forecast, Price & News

GBX 29
+1.00 (+3.57%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
15,000 shs
Average Volume
112,285 shs
Market Capitalization
£8.14 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive IDP News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovaDerma and its competitors with MarketBeat's FREE daily newsletter.

InnovaDerma logo

About InnovaDerma

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Specialty Retail
Year Founded

Sales & Book Value

Annual Sales
£9.82 million
Cash Flow
GBX 5.36 per share
Book Value
GBX 7.90 per share


Pretax Margin




Free Float
Market Cap
£8.14 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

InnovaDerma (LON:IDP) Frequently Asked Questions

How were InnovaDerma's earnings last quarter?

InnovaDerma PLC (LON:IDP) announced its earnings results on Wednesday, September, 30th. The company reported ($2.00) earnings per share for the quarter, missing analysts' consensus estimates of $9.50 by $11.50.
View InnovaDerma's earnings history

Who are InnovaDerma's key executives?
InnovaDerma's management team includes the following people:
  • Mr. Blake G. Hughes, CEO & Exec. Director
  • Mr. Andrew Dunderdale, Group Fin. Director & Exec. Director
  • Mr. Warren Dockary, Group Financial Controller
What other stocks do shareholders of InnovaDerma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InnovaDerma investors own include Sol-Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), BJ's Restaurants (BJRI), Christopher & Banks (CBK), Cidara Therapeutics (CDTX), eHealth (EHTH), Teledyne FLIR (FLIR), Imperial Brands (IMB) and ImmunoGen (IMGN).

What is InnovaDerma's stock symbol?

InnovaDerma trades on the London Stock Exchange (LON) under the ticker symbol "IDP."

How do I buy shares of InnovaDerma?

Shares of IDP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is InnovaDerma's stock price today?

One share of IDP stock can currently be purchased for approximately GBX 29.

How much money does InnovaDerma make?

InnovaDerma has a market capitalization of £8.14 million and generates £9.82 million in revenue each year.

How many employees does InnovaDerma have?

InnovaDerma employs 38 workers across the globe.

What is InnovaDerma's official website?

The official website for InnovaDerma is www.innovaderma.com.

How can I contact InnovaDerma?

The company can be reached via phone at 61 3 9863 8030.

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.